Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:BIOA

(BIOA) (BIOA) Stock Price, News & Analysis

(BIOA) logo

About (BIOA) Stock (NYSE:BIOA)

Advanced Chart

Key Stats

Today's Range
$4.40
$5.00
50-Day Range
N/A
52-Week Range
$2.88
$26.62
Volume
512,188 shs
Average Volume
449,441 shs
Market Capitalization
$166.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.67
Consensus Rating
Reduce

Company Overview

Receive BIOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BIOA) and its competitors with MarketBeat's FREE daily newsletter.

BIOA Stock News Headlines

Bioage Labs Inc BIOA
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
BioAge Labs, Inc. Common Stock (BIOA)
BioAge Labs completes IND-enabling studies for BGE-102
See More Headlines

BIOA Stock Analysis - Frequently Asked Questions

(BIOA) (NYSE:BIOA) issued its earnings results on Thursday, November, 7th. The biotechnology company reported ($6.70) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.62) by $6.08.

(BIOA) (BIOA) raised $198 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 11,000,000 shares at a price of $18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (BIOA) investors own include ProQR Therapeutics (PRQR), Flexion Therapeutics (FLXN), Rite Aid (RAD), LadRx (CYTR), Intellipharmaceutics International (IPCIF), NVIDIA (NVDA) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/07/2024
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:BIOA
CIK
1534287
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$5.00
Potential Upside/Downside
+22.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
35,850,000
Free Float
N/A
Market Cap
$166.52 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:BIOA) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners